The development and evaluation of human skin disease models to analyse medicines.

Completed

• Conditions: Atopic dermatitis; 10014982

• Registration Number: NL-OMON45329
• Lead Sponsor: Derphartox

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 22 July 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 3

Inclusion Criteria

Patients with moderate to severe atopic dermatitis

Exclusion Criteria

Volunteers undergoing UV/light therapy or taking systemic drugs such as cyclosporin A or methotrexate
Volunteers using local topical corticosteroids
Volunteers developing Köbner phenomenon at wound sites

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Cytokine synthesis and release.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>-</p><br>